Thrombophilia panel

Thrombophilia Genetic Testing

Inherited thrombophilias are conditions where the blood has an increased tendency to clot, leading to serious outcomes such as blood vessel blockages, organ clots, pregnancy loss, and intrauterine growth restriction.

To assess these risks, we examine the following gene regions:

  • Factor V Leiden (G1691A)
  • Factor II – Prothrombin (G20210A)
  • MTHFR C677T and MTHFR A1298C

By carefully evaluating the genetic risks related to clotting disorders, clinicians can offer personalized treatment plans to patients, helping to manage and mitigate these risks effectively especially during pregnancy.

"The essence of evolutionary biology is that, just as our genetic material guides us, we also have the potential to guide it."

Richard Dawkins